|Articles|October 15, 2003

Allergan, Syntex involved in patent monopoly case

San Francisco-A federal judge will decide this fall whether a generic formulation of ketorolac tromethamine violates a patent held by Syntex Pharmaceuticals and licensed to Allergan Inc. to make Acular.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME